IBO · Impact Biomedical Inc.
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements the Company has incurred operating losses as well as negative cash flows from operating activities over the past two years. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued.”View the 10-Q filed May 12, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-03-27 | Macko Todd D |
Interim CFO |
Sell↓
|
Common Stock
|
43,400 |
| 2026-03-25 | Macko Todd D |
Interim CFO |
Sell↓
|
Common Stock
|
1,600 |
| 2026-03-23 | Grady Jason |
Director |
Sell↓
|
Common Stock
|
50,000 |
| 2025-05-27 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
45,400 |
| 2025-05-27 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
45,400 |
| 2025-05-22 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
115,600 |
| 2025-05-22 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
115,600 |
| 2025-04-04 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
890,800 |
| 2025-04-03 | Chan Heng Fai Ambrose |
Insider |
Sell↓
Filing footnotes — Common stock (Indirect)
On April 3, 2025, Alset International Limited sold 351,555 shares of the Issuer's common stock at a weighted average sale price of $0.495. This transaction was executed in multiple trades at prices ranging from $0.46 to $0.57. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. |
Common stock
(I)
|
351,555 |
| 2025-03-27 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
47,681 |
| 2025-03-26 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
9,858 |
| 2025-03-26 | DSS, INC. |
10% Owner |
Sell↓
|
Common Stock
|
48,281 |
| 2025-03-21 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This entity is a wholly-owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
166,600 |
| 2025-03-21 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This entity is a wholly-owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
166,600 |
| 2025-03-21 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This entity is a wholly-owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
166,600 |
| 2025-03-20 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
53,280 |
| 2025-03-20 | DSS, INC. |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
200 |
| 2024-12-05 | Heuszel Frank D |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
500 |
| 2024-12-02 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
20 |
| 2024-11-27 | Heuszel Frank D |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
500 |
| 2024-11-26 | Heuszel Frank D |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
550 |
| 2024-11-26 | Heuszel Frank D |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
500 |
| 2024-11-18 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
5,000 |
| 2024-11-13 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
200 |
| 2024-11-12 | DSS, INC. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
500 |
| 2024-09-18 | DSS, INC. |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
1,000 |
| 2024-09-17 | DSS, INC. |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
7,800 |
| 2024-09-16 | Sims Melissa Kaye |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-09-16 | Zimmerman Christian Thomas |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-09-16 | DSS, INC. |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
Common Stock
(I)
|
50,000 |
| 2024-09-16 | Brownell Elise |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-09-16 | Keene David K |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-09-16 | Suseck Mark |
Chief Operating Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-09-16 | Hibbert Castel Berisford |
Director |
Other↑
|
No Securities Owned
|
0 |